25
Participants
Start Date
May 31, 2015
Primary Completion Date
January 31, 2020
Study Completion Date
January 31, 2026
Clofarabine
second-generation purine nucleoside analog
Mount Sinai Medical Center, New York
The Children's Hospital of Pennsylvania, Philadelphia
Children's National Medical Center, Washington D.C.
St. Jude Children's Research Hospital, Memphis
Cincinnati Children's Hospital Medical Center, Cincinnati
Arkansas Children's Hospital, Little Rock
Texas Children's Hospital, Houston
Phoenix Children's Hospital, Phoenix
Children's Hospital of Los Angeles, Los Angeles
University of California San Francisco Medical Center, San Francisco
Massachusetts General Hospital, Boston
Boston Children's Hospital, Boston
Dana-Farber Cancer Institute, Boston
Dana-Farber Cancer Institute, Boston
The Hospital for Sick Children, Toronto
Collaborators (1)
Sanofi
INDUSTRY
St. Baldrick's Foundation
OTHER
Cookies for Kids' Cancer
OTHER
North American Consortium for Histiocytosis
OTHER
Dana-Farber Cancer Institute
OTHER